Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody
NCT05392413
·
clinicaltrials.gov ↗
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Squamous Cell Carcinoma
PD-1 Inhibitor
Sponsor
Nanfang Hospital, Southern Medical University